COMMON STOCK:
ORGANIZATION AND OPERATIONS CONSISTS OF:
Equity Instruments Issued to Parties Other Than Employees for Acquiring Goods or Services
Entire Diclosure for equity instruments issued to parties other than employees for acquiring goods and services
Stock-Based Compensation for Obtaining Employee Services Policy
Effect of exchange rate changes on cash
Cash flows from financing activities:
Due from related party {1}
Due from related party
Common stock issued for acquisition of PPT
Common stock issued for cash at $1.50 per share
Forward stock split
Common Stock Par Value $0.001 Number of Shares
Forgiveness of debt
Interest income
Research and development
Revenues during the development stage
Preferred Stock, par value
Prepaid expenses
Entity Filer Category
Amendment Flag
Common stock in exchange for extinguishment in debt to a related party
Common stock in exchange for extinguishment in debt to a related party
SUBSEQUENT EVENTS {1}
SUBSEQUENT EVENTS
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES {1}
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
ORGANIZATION AND OPERATIONS
Net cash used in operating activities
Other receivables
Changes in operating assets and liabilities:
Cash flows from operating activities:
Cash flows operating activities:
Comprehensive income (loss)
Due from related party
Document Type
Authorized to issue shares
Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies.
Net Income (Loss) per Common Share Policy
Foreign Currency Transactions Policy
RELATED PARTY TRANSACTIONS {1}
RELATED PARTY TRANSACTIONS
Proceeds from the sale of subsidiary
Cash paid for acquisition of PPT shares
Net income
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
CHANGES IN STOCK HOLDERS EQUITY
Other (income) expense
Total Current Liabilities
CURRENT ASSETS:
Document Fiscal Year Focus
Realizing a gain on disposal
Realizing a gain on disposal
Related Parties Policy
Entire policy disclosure for related parties during the period.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Proceeds from issuance of convertible debentures
Prepaid expenses {1}
Prepaid expenses
Accounts receivable {1}
Accounts receivable
Foreign currency translation gain (loss) {1}
Foreign currency translation gain (loss)
Common stock returned to treasury
Common stock returned to treasury
Common stock issued as performance based escrow shares
Common stock issued as performance based escrow shares
Total other (income) expense
Loss from operations
Amortization
Common Stock, shares issued
Common Stock, par value
Advances from related parties
Entity Registrant Name
SHARES AUTHORIZED:
Repaid an aggregate of liabilities
Repaid an aggregate of liabilities
Fair Value of Financial Instruments
Net cash used in investing activities
Forgiveness of obligation to issue shares under contract
Forgiveness of obligation to issue shares under contract
Forgiveness of related party debt
Forgiveness of related party debt
Convertible debentures converted to common stock
Fair value of detachable warrants
Fair value of detachable warrants
Issuance of common stock to consultant at $1.20 per share
Issuance of common stock to consultant at $1.20 per share
Operating expenses:
Common stock: $0.001 par value; 100,000,000 shares authorized; 11,975,645 and 1,975,645 shares issued and outstanding, respectively
Document Fiscal Period Focus
Document Period End Date
Equity Component [Domain]
Director and Officer Forgave Indebtedness due from the Company
Director and Officer Forgave Indebtedness due from the Company
ADVANCES FROM SOLE DIRECTOR AND OFFICER:
Consideration to a third party
Consideration to a third party
Development Stage Company
Cash at end of period
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Cash at beginning of period
Cash at beginning of period
Gain on sale of subsidiary
Gain (loss) on entity's disposition of equity in securities of subsidiaries. Reflects the difference in the parent company's carrying amount of the equity interest in the subsidiary immediately before and after all stock transactions.
Release of 75,000 shares from escrow
Release of 75,000 shares from escrow
Interest on convertible debt converted to common stock
Interest on convertible debt converted to common stock
Cash payment for unsuccesful due diligence
Cash payment for unsuccesful due diligence
Net loss per common share: Basic and diluted
Income tax provision
Loss on sale of intellectual property
PACIFIC PHARMA TECHNOLOGIES:
Realizing a gain on disposal [Abstract]
Income tax paid
Accretion of convertible debenture
Amortization of fair value of stock options granted.
Amortization of fair value of stock options granted.
Professional fees
Consulting fees
Amount charged during the reporting period for consulting fees.
Revenues:
Accumulated other comprehensive income (loss):
Entity Common Stock, Shares Outstanding
Entity Central Index Key
Subsequent Events Policy
Accounts Receivable and Allowance for Doubtful Accounts Policy
Advances from (repayment made to) related party
Accounts payable and accrued liabilities {1}
Accounts payable and accrued liabilities
Adjustments to reconcile net loss to net cash used in operating activities:
Common stock issued for amended and restated contract at $0.25 per share
Common stock issued for amended and restated contract at $0.25 per share
Issuance of stock for BCCA license fee
Issuance of stock for BCCA license fee
Weighted average common shares outstanding: Basic and diluted
License fees and royalties
Total Liabilities and Stockholders' Deficit
Proceeds from issuance of common shares, net
Cash flows from investing activities:
Stock-based compensation.
Common stock issued for future services ending January 31, 2008 at $0.30 per share.
Common stock issued for future services ending January 31, 2008 at $0.30 per share
Amortization of fair value of stock options granted
Statement {1}
Statement
Accumulated other comprehensive income (loss) Foreign currency translation gain (loss)
Common Stock Amount
Asset impairment loss
Management compensation
Deficit accumulated during the development stage
Basis of Presentation - Unaudited Interim Financial Information
ACCOUNTING POLICIES
Common stock issued for debt
Common stock issued for debt
Share issued for cash
Share issued for cash
Forgiveness of deferred compensation due to cancellation of escrow shares
Forgiveness of deferred compensation due to cancellation of escrow shares
Statement
Loss on foreign exchange translations
Common Stock, shares outstanding
Additional paid-in capital
LIABILITIES AND STOCKHOLDERS' DEFICIT
Document and Entity Information
Issued shares of common stock
Issued shares of common stock
Authorized to issue sharesPreferred Stock
Authorized to issue sharesPreferred Stock
Asset impairment
Shares issued or to be issued for services
Equity Components
Interest and finance charges
Compensation shares
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
STOCKHOLDERS' DEFICIT:
Accounts payable and accrued liabilities
Entity Current Reporting Status
Due to directors and officers
Recently Issued Accounting Pronouncements
STOCKHOLDERS' EQUITY (DEFICIT)
ORGANIZATION AND OPERATIONS {1}
ORGANIZATION AND OPERATIONS
Supplemental disclosure of cash flows information:
Amortization {1}
Amortization
Amortization of stock issued for operating expenses
Amortization of stock issued for operating expenses
Embedded beneficial conversion feature
Recapitalization adjustment
Recapitalization adjustment
(Gain) loss on sale of subsidiary
Investor and corporate communications
Common Stock, shares authorized
Parentheticals
Preferred stock: $0.001 par value; 100,000,000 shares authorized;none issued or outstanding
Shares of common stock per share
Shares of common stock per share
Shares of Preferred Stock per share
Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.
Resulting in a loss on disposal
Resulting in a loss on disposal
Revenue Recognition
Cash Equivalents Policy
Use of Estimates and Assumptions
Reclassification
Loss from sale of intellectual property
Balance
Balance
Balance
Preferred Stock, shares authorized
Foreign currency translation gain (loss)
CURRENT LIABILITIES:
Total Current Assets
Cash
Entity Voluntary Filers
Gross proceeds of
Gross proceeds of shares
Issued shares of common stock per share
Issued shares of common stock per share
SUBSEQUENT EVENTS
GOING CONCERN {1}
GOING CONCERN
Common stock issued for achieving Malaria milestone at $0.3624 per share
Common stock issued for achieving Malaria milestone at $0.3624 per share
Amortization of stock issued for operating expenses.
Amortization of stock issued for operating expenses.
Less amount expensed
Less amount expensed
Additional Paid-in Capital
Loss before income tax provision
General and administrative expenses
ASSETS
Entity Well-known Seasoned Issuer
Authorized to issue shares common stock
Authorized to issue shares common stock
Income Tax Provision Policy
STOCKHOLDERS' EQUITY (DEFICIT) {1}
STOCKHOLDERS' EQUITY (DEFICIT)
RELATED PARTY TRANSACTIONS
GOING CONCERN
Net change in cash
Purchase of equipment
Deferred income tax
Compensation shares.
Partial forfeiture of convertible debenture
Shares issued to former shareholders of Upstream Canada
Shares issued to former shareholders of Upstream Canada
Other (income) expense:
Accounts receivable
Pacific Pharma sold to JTAT Consulting for the payment
Pacific Pharma sold to JTAT Consulting for the payment
Uncertain Tax Positions
Net cash provided by financing activities
Due to related parties
Net loss {1}
Net loss
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Obligation to issue shares under contract.
Obligation to issue shares under contract.
Shares cancelled on acquisition
Shares cancelled on acquisition
Total Stockholders' Equity (Deficit).
Deficit Accumulated During the Development Stage
Net loss
Entity Public Float
Cancellation of obligation to issue shares with a value
Cancellation of obligation to issue shares with a value
Cash Flows Reporting
Entire policy disclosure for cash flows reporting
Commitment and Contingencies
Fiscal Year-End Policy
Interest paid
Net loss {2}
Net loss
Foreign exchange translation adjustment
Issuance of common stock per agreement
Issuance of common stock per agreement
Common stock issued for future services ending January 31, 2008 at $0.30 per share
Common stock issued for future services ending January 31, 2008 at $0.30 per share
Obligation to issue shares under contract
Obligation to issue shares under contract
Common stock issued for future services
Total operating expenses
Stock-based compensation
Total Stockholders' Deficit
Total Assets
Current Fiscal Year End Date